Literature DB >> 11140798

D-dimer assays for the exclusion of venous thromboembolism.

G Reber1, P de Moerloose.   

Abstract

Many assay systems for D-dimer measurement are available. Their intended use is mainly the exclusion of venous thromboembolism (VTE). Despite standardization attempts, an important variability in assay results is observed, and therefore data obtained by use of one assay cannot be extrapolated to another assay. As a consequence, each assay must be validated in appropriate clinical trials to determine its cut-off value for VTE exclusion. The differences observed can be explained by the heterogeneity of fibrin degradation products present in patient samples, by the reactivity of the various antibodies and their combinations, and by the differences in calibrators and in the format of assays. Among the different assay systems available, the use of automated, observer-independent tests having good analytical sensitivity is highly recommended. The assay should also exhibit a high sensitivity for VTE exclusion to be used as the first step of any diagnostic strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140798     DOI: 10.1055/s-2000-13217

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  2 in total

1.  VEGF Inhibitors Do Not Increase D-dimer Levels in Colorectal Cancer Patients Without Venous Thromboembolism: A Retrospective Non-inferiority Analysis

Authors:  Hirokazu Toshima; Toshikazu Ikusue; Atsushi Hisamatsu; Kouji Kobayashi; Hiroo Ishida; Ken Shimada
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

2.  Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.

Authors:  Samantha J Donkel; Boutaina Benaddi; Diederik W J Dippel; Hugo Ten Cate; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.